These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26679299)

  • 1. Impact of omalizumab therapy on medication requirements for chronic rhinosinusitis.
    Chandra RK; Clavenna M; Samuelson M; Tanner SB; Turner JH
    Int Forum Allergy Rhinol; 2016 May; 6(5):472-7. PubMed ID: 26679299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of omalizumab (Xolair®) in patients with moderate to severe predominately chronic oral steroid dependent asthma in Taiwan: a retrospective, population-based database cohort study.
    Chen HC; Huang CD; Chang E; Kuo HP
    BMC Pulm Med; 2016 Jan; 16():3. PubMed ID: 26747278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of omalizumab on pulmonary function in patients with allergic asthma with and without chronic rhinosinusitis.
    Clavenna MJ; Turner JH; Samuelson M; Tanner SB; Duncavage J; Chandra RK
    Allergy Asthma Proc; 2016; 37(1):23-6. PubMed ID: 26831843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical option of omalizumab on refractory vasospastic angina with asthma and eosinophilic chronic rhinosinusitis.
    Hamada S; Tatsumi S; Taniguchi T; Yasuba H
    J Allergy Clin Immunol Pract; 2016; 4(4):753-5. PubMed ID: 27017534
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma.
    Tajiri T; Matsumoto H; Hiraumi H; Ikeda H; Morita K; Izuhara K; Ono J; Ohta S; Ito I; Oguma T; Nakaji H; Inoue H; Iwata T; Nagasaki T; Kanemitsu Y; Ito J; Niimi A; Mishima M
    Ann Allergy Asthma Immunol; 2013 May; 110(5):387-8. PubMed ID: 23622013
    [No Abstract]   [Full Text] [Related]  

  • 6. [The efficacy of omalizumab in the treatment of chronic rhinosinusitis with nasal polyps: a discussion of 2 refractory cases].
    Jandus P; Harr T; Soyka MB; Landis BN
    Rev Med Suisse; 2019 Oct; 15(665):1748-1751. PubMed ID: 31580018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study.
    Bidder T; Sahota J; Rennie C; Lund VJ; Robinson DS; Kariyawasam HH
    Rhinology; 2018 Mar; 56(1):42-45. PubMed ID: 29288573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No difference in omalizumab efficacy in patients with asthma by number of asthma-related and allergic comorbidities.
    Chen M; Choo E; Yoo B; Raut P; Haselkorn T; Pazwash H; Holweg CTJ; Hudes G
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):666-673. PubMed ID: 33465457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.
    Navinés-Ferrer A; Serrano-Candelas E; Molina-Molina GJ; Martín M
    J Immunol Res; 2016; 2016():8163803. PubMed ID: 28097159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of anti-IgE therapy beyond allergic asthma.
    Stokes JR; Casale TB
    J Allergy Clin Immunol Pract; 2015; 3(2):162-6. PubMed ID: 25609342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis.
    Pinto JM; Mehta N; DiTineo M; Wang J; Baroody FM; Naclerio RM
    Rhinology; 2010 Sep; 48(3):318-24. PubMed ID: 21038023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: a 6-year pragmatic data review.
    Storms W; Bowdish MS; Farrar JR
    Allergy Asthma Proc; 2012; 33(2):172-7. PubMed ID: 22525394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.
    Chipps BE; Figliomeni M; Spector S
    Allergy Asthma Proc; 2012; 33(5):377-85. PubMed ID: 23026179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab for chronic rhinosinusitis.
    Brañes R; Rosenbaum A; Callejas C; Winter M
    Medwave; 2018 Nov; 18(7):e7347. PubMed ID: 30507897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between systemic antibiotic and corticosteroid use for chronic rhinosinusitis and quality of life.
    Yamasaki A; Hoehle LP; Phillips KM; Feng AL; Campbell AP; Caradonna DS; Gray ST; Sedaghat AR
    Laryngoscope; 2018 Jan; 128(1):37-42. PubMed ID: 28731529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality.
    Holgate S; Bousquet J; Wenzel S; Fox H; Liu J; Castellsague J
    Curr Med Res Opin; 2001; 17(4):233-40. PubMed ID: 11922396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
    Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
    Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience.
    Chipps BE; Lanier B; Milgrom H; Deschildre A; Hedlin G; Szefler SJ; Kattan M; Kianifard F; Ortiz B; Haselkorn T; Iqbal A; Rosén K; Trzaskoma B; Busse WW
    J Allergy Clin Immunol; 2017 May; 139(5):1431-1444. PubMed ID: 28477722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab Is Equally Effective in Persistent Allergic Oral Corticosteroid-Dependent Asthma Caused by Either Seasonal or Perennial Allergens: A Pilot Study.
    Domingo C; Pomares X; Navarro A; Rudi N; Sogo A; Dávila I; Mirapeix RM
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy with omalizumab in patients with severe persistent allergic asthma: a real life data in Turkey].
    Bavbek S; Aydın O; Kepil Özdemir S; Yılmaz I; Celik GE; Demirel YS; Mungan D; Sin B; Kurşun N; Mısırlıgil Z
    Tuberk Toraks; 2010; 58(4):425-34. PubMed ID: 21341120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.